Microbot Medical (NASDAQ:MBOT) Price Target Lowered to $7.00 at HC Wainwright

Microbot Medical (NASDAQ:MBOT – Free Report) had its target price decreased by HC Wainwright from $8.00 to $7.00 in a report released on Tuesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for Microbot Medical’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 […]

Related Keywords

United Kingdom , ,Microbot Medical Inc ,Renaissance Technologies ,Microbot Medical Company Profile ,York Mellon Corp ,Armistice Capital ,Dimensional Fund Advisors ,Vanguard Group Inc ,Microbot Medical ,Free Report ,Medical Trading Down ,Fund Advisors ,New York Mellon Corp ,Get Free Report ,Medical Inc ,Microbot Medical Daily ,Nasdaq Mbot ,Imbot ,Medical ,Lower Price Target ,Hc Wainwright ,